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Abstract
Background: Most HIV-seropositive subjects in western countries receive highly active antiretroviral therapy (HAART).
Although many aspects of their health have been studied, little is known about their vestibular and balance function. The
goals of this study were to determine the prevalences of vestibular and balance impairments among HIV-seropositive and
comparable seronegative men and women and to determine if those groups differed.
Methods: Standard screening tests of vestibular and balance function, including head thrusts, Dix-Hallpike maneuvers, and
Romberg balance tests on compliant foam were performed during semiannual study visits of participants who were
enrolled in the Baltimore and Washington, D. C. sites of the Multicenter AIDS Cohort Study and the Women’s Interagency
HIV Study.
Results: No significant differences by HIV status were found on most tests, but HIV-seropositive subjects who were using
HAART had a lower frequency of abnormal Dix-Hallpike nystagmus than HIV-seronegative subjects. A significant number of
nonclassical Dix-Hallpike responses were found. Age was associated with Romberg scores on foam with eyes closed. Sex
was not associated with any of the test scores.
Conclusion: These findings suggest that HAART-treated HIV infection has no harmful association with vestibular function in
community-dwelling, ambulatory men and women. The association with age was expected, but the lack of association with
sex was unexpected. The presence of nonclassical Dix-Hallpike responses might be consistent with central nervous system
lesions.
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Introduction
A few studies have reported that HIV infection is associated
with vestibular impairment, especially among individuals with
advanced HIV disease [1,2]. Those studies were limited by being
performed before the availability of highly active combination
antiretroviral drug regimens [3,4,5,6,7]; small sample sizes
[2,5,6,8,9]; use of participants with progressive HIV disease who
also had chronic, non-vertiginous dizziness [2], or who had been
given ototoxic medications [5,6]; or use of only indirect tests of
vestibular function [5,10].
In one report patients with advanced HIV disease had more
signs of central vestibular impairments than patients with less
advanced disease but the level of HIV disease was not related to
the incidence of peripheral vestibular impairments [11]. In
another report HIV-seropositive (HIV+) subjects without neuro-
logic symptoms but with increased latencies of auditory brainstem
responses, decreased smooth pursuit, and decreased saccadic eye
movements, had normal peripheral vestibular function as in-
dicated by bi-thermal caloric test scores [8]. Those test results
suggested that subjects had central neurologic involvement. Small
post-mortem studies have shown histopathologic changes in the
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complications [12]. Therefore, the relationship between HIV
infection and vestibular function among community-dwelling,
ambulatory adults remains unclear. The virus may affect the
vestibular system directly and the central vestibular pathways
indirectly via opportunistic infections that may cause secondary
influences [13].
The vestibular system controls the vestibulo-ocular reflex (VOR)
through specific brainstem nuclei that control signals to the extra-
ocular muscles. Therefore, screening and diagnostic tests of the
VOR assess vestibular function directly. Two widely used
screening tests of the VOR are the head thrust test, which detects
abnormal function of the horizontal semicircular canal or superior
vestibular nerve [14,15,16], and the Dix-Hallpike maneuver [17],
which is the standard test for benign paroxysmal positional vertigo
(BPPV) of the posterior semicircular canal. Balance testing is an
indirect measure of vestibular function because vestibular input to
the spinal cord via the vestibulospinal tracts is one of several
contributions to balance. Variations of the Romberg test are
widely used for diagnostic tests on computerized force platforms
[18] and for screening on non-computerized compliant foam
[19,20,21].
In the present study we used the head thrust test, Dix-Hallpike
maneuver, and Romberg tests to screen HIV+ and HIV-
seronegative (HIV2) men and women who were participating in
two longitudinal cohort studies. The goal was to determine if
HIV+ people treated with HAART had a higher prevalence of
vestibular disorders than HIV2 people of comparable age, sex
and racial/ethnic backgrounds.
Methods
Ethics Statement
The Institutional Review Boards for Johns Hopkins University,
Georgetown University, Whitman-Walker Health and Baylor
College of Medicine approved this study. All participants signed
informed consent prior to participating.
Study Sample
Participants from the Baltimore-Washington, DC site of the
Multicenter AIDS Cohort Study (MACS) and the Washington,
DC site of the Women’s Interagency HIV Study (WIHS) were
enrolled in this study. The MACS and WIHS are ongoing
longitudinal studies of the natural and treated histories of HIV
infection in men and women, respectively; the study designs have
been described elsewhere [22,23,24]. Only methods relevant to
the present study are presented here.
Every six months MACS and WIHS participants complete
comprehensive physical examinations and provide blood speci-
mens for CD4+ and CD8+ T cell counts by standardized flow
cytometry [25] and for plasma HIV RNA determination. In the
MACS, HIV RNA was measured using the COBAS Ultrasensitive
Amplicor HIV-1 monitor assay (Roche Molecular Systems,
Branchburg, NJ), sensitive to 50 copies HIV RNA/mL. In the
WIHS, HIV RNA was measured using COBAS AmpliPrep/
COBAS TaqMan HIV–1 Test (Roche Molecular Systems,
Branchburg, NJ), sensitive to 48 copies HIV RNA/mL. Partici-
pants also complete interviewer-administered questionnaires, in-
cluding questions about medical conditions, medical treatments,
sexual behavior, illegal drug use, and cigarette and alcohol
consumption since the previous visit. Self-reported use of
antiretroviral medications is summarized at each visit to define
whether participants have ever used mono- or combination
antiretroviral therapy [26], or highly active antiretroviral therapy
(HAART) [27].
Participants were excluded from the present study if they had
had spinal injury, radiation to the neck or spine, vestibular
impairment, or use of narcotics, antihistamines or sedatives within
48 hours of testing because those medications have inhibitory
effects on the vestibular system.
Testing Paradigm
Head thrust test. To perform the head thrust test [15] the
examiner sat in front of the subject, instructed the subject to stare
at the examiner’s nose, held the subject’s head with both hands,
and rapidly turned the head approximately 10u to the left or right.
The expected eye movement was a smooth, slow rotation of the
eye away from the direction of the stimulus, representing the
VOR. The test was rated as abnormal if the observer saw a catch-
up saccade, i.e. a rapid, jumping motion of the eye that occurs if
the VOR does not compensate well for the head movement. An
abnormal response is consistent with impaired horizontal semi-
circular canal or superior vestibular nerve function.
Other eye movement tests. During the other eye movement
tests, i.e., spontaneous nystagmus, gaze-evoked nystagmus, and
Dix-Hallpike maneuvers, subjects wore goggles fitted with
a monocular infra-red video-oculography camera (VOG) that
recorded eye movements while the eyes were open in darkness to
avoid the influence of vision on the responses. For all eye
movement tests performed with VOG the outcome variable was
nystagmus, i.e., a repetitive eye movement with alternating slow
and fast phases.
Spontaneous nystagmus and gaze-evoked nystagmus were tested
first, for quality control. Spontaneous nystagmus that occurs
during quiet sitting in darkness indicates either an acute vestibular
impairment or a central neurologic lesion. Eye movements were
recorded while the subject sat quietly, in darkness, for at least
10 seconds. The presence of spontaneous nystagmus was consid-
ered abnormal. Gaze-evoked nystagmus, i.e. nystagmus elicited by
lateral gaze, indicates either advanced age or a lesion in the central
oculomotor pathway. Gaze-evoked nystagmus was recorded by
asking the subject to look to the right or left by moving the eyes
without moving the head. The presence of more than 2 beats of
nystagmus was rated as abnormal.
The Dix-Hallpike maneuver [17] was administered by turning
the front of the participant’s head approximately 45u toward the
test side, and then rapidly tilting the individual backward from the
long-sitting position into the supine-lying position on the treatment
table, with the head hanging off the end of the table and pitched
upward approximately 30u while supported by the examiner’s
hand [28]. The head is typically held still for up to 30 seconds to
observe for the onset of nystagmus. If nystagmus occurred the
examiner waited until it stopped before allowing the subject to sit
up. VOG recordings were subsequently reviewed by one of three
observers who were not otherwise involved in the study, and who
were expert raters with 7 to 20 years of experience performing this
kind of vestibular testing.
Nystagmus elicited by the Dix-Hallpike maneuver was consid-
ered abnormal and was designated as classical or nonclassical
[28,29]. A classical pattern of nystagmus is characterized by a delay
of several seconds before the onset of eye movement, during which
a few low amplitude beats are followed by a brief ‘‘burst’’ of high
amplitude nystagmus and then a decline in amplitude over 3 to
60 seconds; the nystagmus has horizontal and torsional compo-
nents with the quick phase beating toward the stimulus side, and
a vertical component with the quick phase beating upward.
Nystagmus which did not fit the classical pattern was defined as
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the posterior semicircular canal. Nonclassical nystagmus is
consistent with either BPPV of an anterior semicircular canal or
a lesion in the central vestibular pathways. Anterior canal BPPV is
rare.
Balance testing. Participants performed Romberg standing
balance tests without shoes, but while wearing socks to standardize
footwear [30,31,32], on the floor and on 10.2 cm thick, medium
density, SunmateH compliant foam (Dynamic Systems, Leicester,
NC), with heels and toes together and arms crossed. The four test
conditions were: eyes open on the floor, eyes closed on the floor,
eyes open on the foam, and eyes closed on the foam (ECF). Of
these conditions ECF is the most consistent with a vestibular
impairment because vision was unavailable and kinesthetic and
somatosensory input through the soles of the feet were not reliable
sources of information, so the individual had to rely more on
vestibular signals. Each trial of Romberg testing was performed for
a maximum of 30 seconds. A participant who did not maintain
balance for 30 seconds was given a second trial. Failure to
maintain balance on the second trial for 30 seconds was
considered abnormal [19].
Statistical Analysis
Descriptive measures were sex; age at time of testing; race/
ethnicity; CD4+ and CD8+ T cell counts and log10 plasma HIV
RNA at the study visit closest to the date of the test; currently
taking HAART at the time of testing (yes/no); ever having used
monotherapy, combination antiretroviral therapy (ART), or
HAART; nadir CD4+ T cell count; peak CD8+ T cell count;
and T-cell counts at the study visit just prior to the time of testing.
Data on each outcome variable were coded as normal or
abnormal using the definitions given above. The following
outcome variables were analyzed using separate multivariable
logistic regression models: Dix-Hallpike any nystagmus, Dix-
Hallpike non-classical nystagmus, Romberg (ECF), and gaze-
evoked nystagmus. The number of Dix-Hallpike classical nystag-
mus responses, head thrust responses, and spontaneous nystagmus
were too small for multivariable modeling. Models were run using
data from the combined HIV+ and HIV-participants and HIV+
participants only. The models using the combined population
were adjusted for HIV status, sex, race/ethnicity (black or non-
black), and age at testing. Additional covariates for models
including only the HIV+ participations were: current CD4+ T
cell count; current CD8+ T cell count; log10 plasma HIV RNA;
ever monotherapy (yes or no); ever combination therapy (yes or
no); and current HAART use (yes or no). In some analyses nadir
CD4+ T cell count and peak CD8+ T cell count were included as
covariates instead of the current T cell counts.
Results
From March 2008 to September 2010 545 potential partici-
pants were screened for eligibility for the study prior to testing. Six
people (1 HIV2 woman; 2 HIV+ men, 3 HIV2 men) declined to
participate in the screening process. Also, for one or more of the
following reasons 92 people were excluded: use of anti-nausea/
vertigo medication, tranquilizer, sedatives, etc., in last 48 hours
(n=30); history of head or neck trauma including surgery or
radiation to ear or neck (n=23); use of a prosthetic leg or gait aid
(n=19); weight more than 136 kg (n=18); lower limb injury or
use of lower extremity orthosis (n=15); history of spinal disease of
neck (n=8); paralysis of extremity on one side of body (n=4);
recent use of erectile dysfunction drugs and/or alcohol (n=2);
history of Meniere’s disease (n=1). After exclusions 447 partic-
ipants (mean age=51.3 years, SD=10.3 years) completed balance
and vestibular testing, including 294 men (65.8%) and 153 (34.2%)
women.
Table 1 shows the demographic characteristics of the
participants. Fewer women were HIV2 than HIV+, but the ages
of all groups were similar. Most HIV+ participants i.e., 82% of
women and 92% of men, had taken HAART at some point and
most participants, i.e. 70% of women and 83% of men, were
taking HAART at the time of data collection. Women and men
differed on some measures. More women than men were black,
and more women had been diagnosed with AIDS prior to the year
preceding testing (36% vs. 17%). Virologic suppression to
undetectable levels was lower among women than men (50% vs.
79%) but the mean CD4+ and CD8+ T cell counts were
comparable.
Dix-Hallpike Maneuver
As each person has 2 vestibular labyrinths, one in each inner
ear, six patterns of responses were possible: (actual numbers of
subjects given in parentheses): negative bilaterally (249); negative
unilaterally and positive, classical unilaterally (3); negative
unilaterally and positive, nonclassical unilaterally (87); positive,
classical bilaterally (3); positive, nonclassical bilaterally (68);
positive, classical unilaterally and positive, nonclassical unilaterally
(3). The notable findings are: a) most subjects were negative,
bilaterally, b) few subjects had unilateral classical nystagmus, c)
many more subjects had nonclassical nystagmus unilaterally or
bilaterally.
As indicated in Table 2 the overall prevalence of nystagmus
was approximately 40%, slightly higher among women than men.
The frequency was slightly, but not statistically significantly, higher
among HIV+ compared to HIV2 females. Multivariable analyses
showed that HIV+ participants who were using HAART at the
time of testing had a lower likelihood of having any nystagmus,
which approached significance (OR=0.47, 95% CI: 0.2, 1.03).
The lower likelihood of having any nystagmus was associated with
higher viral loads; that association approached statistical signifi-
cance (OR=0.74, CI=0.52, 1.05).
The overall prevalence of classical nystagmus was higher among
the HIV2 participants compared to the HIV+ participants, but
the groups did not differ significantly (3.7% vs 0.9%, p=0.09).
The prevalence was, however, significantly higher among the
HIV2 women compared to HIV+ women (12.5% vs 1%,
p=0.009) only. See Table 2.
The overall prevalence of nonclassical nystagmus was approx-
imately 40%, similar to the value for any nystagmus. HIV+
participants currently using HAART had a lower likelihood of
nonclassical nystagmus, which approached statistical significance
(OR=0.50, CI: 0.23, 1.11). Multivariable analysis showed that
HIV+ participants who had never used HAART had a significantly
higher risk of having nonclassical nystagmus (OR=2.62, CI: 1.1,
6.23) compared to HIV+ subjects who had never used HAART.
No association was found between age, sex or race/ethnicity
and any of the dependent variables in any of the models we tested.
See Tables 3 and 4 for data on any nystagmus and nonclassical
nystagmus.
Head Thrust Test and Spontaneous Nystagmus
No women and few men (9.8% of HIV+ and 21.1% of HIV2)
had positive head thrust tests. Few subjects in each group had
spontaneous nystagmus (3.1% HIV+ and 5.2% HIV2). See
Table 2.
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The overall prevalence of gaze-evoked nystagmus was approx-
imately 39%, as indicated in Table 2. This prevalence was
unexpectedly high. Being black appeared to be related to a lower
risk of having gaze-evoked nystagmus in the combined HV+ and
HIV2 group (OR=0.50, CI: 0.32, 0.80) and in the HIV+ group
alone, (OR=0.47, CI: 0.26, 0.87). Among HIV+ participants, the
presence of gaze-evoked nystagmus was unrelated to CD4+ or
CD8+ T cell counts, or use of antiretroviral medications.
Multivariable analyses showed that in the HIV+ group current
use of HAART was associated with a lower likelihood of having
gaze-evoked nystagmus, which approached statistical significance
(OR=0.45, CI: 0.2, 1.03); the level of HIV RNA was inversely
associated with the risk of having a positive response (OR=0.66
per log increase, CI: 0.45, 0.96). The results were not related to
age or sex. These findings must be interpreted with caution,
however, due to the small number of subjects who had positive
responses. See Tables 3 and 4.
Table 1. Enrollment characteristics of sample.
HIV+ HIV2
Men Women All HIV+ Men Women All HIV2
Total, n 126 121 247 168 32 200
Age, mean (SD), yrs 52.0 (8.0) 45.6 (8.6) 48.9 (8.9) 56.7 (9.5) 40.9 (10.2) 54.2 (11.2)
Race, n (%)
Non-black 58 (46.0) 26 (21.5) 84 (34.0) 134 (79.8) 9 (28.1) 143 (71.5)
Black 68 (54.0) 95 (78.5) 163 (66.0) 34 (20.2) 23 (71.9) 57 (28.5)
Ever AIDS, n (%) 22 (17.5) 44 (36.4) 66 (26.7)
Ever mono, n (%) 37 (29.4) 47 (38.8) 84 (34.0)
Ever combo, n (%) 59 (46.8) 70 (57.9) 129 (52.2)
Ever HAART, n (%) 116 (92.1) 99 (81.8) 215 (87.0)
Current HAART, n (%) 105 (83.3) 85 (70.3) 190 (76.9)
Nadir CD4+ T cell count,
mean (SD)
281.5 (174.1) 258.6 (183.0) 270.2 (178.5)
Current CD4+ T cell count,
mean (SD)
568.8 (277.0) 543.6 (291.7) 556.4 (284.0)
Peak CD8+ T cell count,
mean (SD)
1468.8 (699.8) 1371.7 (656.5) 1421.3 (679.3)
Current CD8+ T count,
mean (SD)
910.2 (403.4) 805.4 (361.9) 858.8 (386.4)
Undetectable HIV RNA,
n (%)
99 (78.6) 60 (49.6) 159 (64.4)
Log10 HIV RNA, median
(IQR)
3.94 (2.91, 4.45) 3.44 (2.67, 4.40) 3.50 (2.68, 4.42)
Ever AIDS, ever diagnosed with AIDS; Ever mono, ever used monotherapy; Ever combo, ever used combination HAART and monotherapy; Ever HAART, ever used
HAART. Undetectable HIV RNA, subjects with undetectable levels of HIV RNA; Log10 HIV RNA, log level of HIV RNA among HIV+ participants with detectable levels of
RNA (n=27 men and 61 women).
doi:10.1371/journal.pone.0038419.t001
Table 2. Frequency distribution of abnormal testing outcomes.
HIV+, n (%) HIV2, n(%)
Men Women All HIV+ Men Women All HIV2
Total 126 121 247 168 32 200
Dix-Hallpike any nystagmus
* 44 (37.3) 49 (44.1) 93 (40.6) 58 (37.2) 13 (40.6) 71 (37.8)
Dix-Hallpike classical nystagmus 1 (0.9) 1 (0.9) 2 (0.9) 3 (1.9) 4 (12.5) 7 (3.7)
Dix-Hallpike nonclassical nystagmus 43 (36.4) 48 (43.2) 91 (39.7) 55 (35.3) 9 (28.1) 64 (34.0)
Head Thrust test 12 (9.8) 0 12 (5.0) 35 (21.1) 0 35 (17.7)
Romberg ECF 21 (17.7) 16 (13.6) 37 (15.6) 24 (14.7) 3 (9.4) 27 (13.9)
Spontaneous nystagmus 5 (4.3) 2 (1.8) 7 (3.1) 7 (4.4) 3 (9.4) 10 (5.2)
Gaze-evoked nystagmus 47 (39.8) 40 (36.4) 87 (38.2) 68 (42.8) 12 (37.5) 80 (41.9)
*Dix-Hallpike any nystagmus=Dix-Hallpike classical nystagmus+Dix-Hallpike nonclassical nystagmus.
doi:10.1371/journal.pone.0038419.t002
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The overall prevalence of failure to stand during ECF for
30 seconds was 16% in men and 12.7% in women, slightly higher
in HIV+ than HIV2 subjects. See Table 2. The response was
significantly related to subject age in multivariable models for both
the combined sample (OR=2.42, CI: 1.73, 3.39) and for the
HIV+ sample (OR=2.51, CI: 1.49, 4.21), but was not significantly
associated with sex, race/ethnicity, CD4+ and CD8+ T cell
counts, plasma HIV RNA, or use of antiretroviral medications.
See Tables 3 and 4.
Secondary Statistical Analyses
The results of additional models, including covariates such as
nadir CD4+ T cell counts (replacing current CD4+ T cell count),
peak CD8+ T cell counts (replacing current CD8+ T cell count)
and ever using HAART (replacing current HAART use) did not
differ significantly from the original models for head thrust,
Romberg ECF or gaze-evoked nystagmus (data not shown). Ever
having used HAART approached statistical significance with
classical nystagmus and was significantly related to nonclassical
nystagmus elicited by Dix-Hallpike maneuvers.
Discussion
Peripheral vestibular impairment was not associated with
HAART-treated HIV infection, as indicated by lack of significant
difference between HIV+ and HIV2 men and women on the
head thrust test, Dix-Hallpike maneuver, and Romberg tests.
These results differ from earlier findings [1,11] that suggested
a strong association of vestibular impairment among individuals
who had more advanced HIV disease. The study by Hausler et al
1.
was performed before the advent of current antiretroviral
medication regimens. Thus, the earlier findings do not apply to
our sample of community-dwelling, HIV-infected individuals,
most of whom were receiving HAART and had had at least some
immune reconstitution.
In the general population BPPV is more common than other
vestibular disorders, common in middle age, increases in
frequency with age, and is approximately twice as prevalent in
women as in men until old age [33,34]. In that context several
findings are noteworthy: 1) the lower likelihood of having positive
responses among HIV+ subjects who used HAART; 2) the higher
odds of having nonclassical nystagmus among subjects who had
never used HAART; 3) the similar prevalences of classical Dix-
Hallpike responses in HIV+ women and men, and 4) the lower
prevalence of classical Dix-Hallpike responses among HIV+
women compared to HIV2 women. The latter statement must
Table 3. Multivariable odds ratios (with 95% confidence intervals) from multiple logistic regression analysis for combined HIV+
and HIV2.
Dix-Hallpike any
nystagmus
Dix-Hallpike
non-classical
nystagmus Romberg ECF Gaze-evoked nystagmus
Age per 10 yrs increase 1.09 (0.87, 1.37) 1.14 (0.91, 1.43) 2.42 (1.73, 3.39)
* 1.01 (0.81, 1.26)
Black vs. non-black 1.03 (0.65, 1.62) 1.06 (0.67, 1.68) 1.89 (0.97, 3.69)
# 0.50 (0.32, 0.8)
*
Female vs. male 1.31 (0.8, 2.15) 1.17 (0.71, 1.93) 1.1 (0.54, 2.24) 1.03 (0.62, 1.7)
HIV+ not HAART 1.41 (0.72, 2.78) 1.66 (0.84, 3.29) 1.93 (0.73, 5.07) 1.35 (0.67, 2.7)
HIV+ HAART 0.98 (0.62, 1.54) 1.17 (0.73, 1.85) 1.43 (0.73, 2.8) 1.04 (0.66, 1.63)
*Statistically significant at p,0.05.
#Statistically significant at p,0.09.
doi:10.1371/journal.pone.0038419.t003
Table 4. Multivariable odds ratios (with 95% confidence intervals) from multiple logistic regression analysis for HIV+ only.
Dix-Hallpike any
nystagmus
Dix-Hallpike
non-classical
nystagmus Romberg ECF Gaze-evoked nystagmus
Age per 10 yrs increase 1.147 (0.8, 1.65) 1.1 (0.76, 1.58) 2.51 (1.49, 4.21)
* 0.91 (0.63, 1.32)
Black vs. non-black 1.419 (0.77, 2.61) 1.32 (0.72, 2.43) 1.33 (0.56, 3.13) 0.47 (0.26, 0.87)
*
Female vs. male 1.433 (0.75, 2.73) 1.43 (0.75, 2.72) 1.32 (0.54, 3.2) 1.06 (0.55, 2.05)
Current HAART 0.47 (0.21, 1.03)
# 0.50 (0.23, 1.11)
# 0.68 (0.23, 2.02) 0.45 (0.2, 1.03)
#
Ever Combo 1.18 (0.63, 2.23) 1.21 (0.64, 2.27) 0.88 (0.37, 2.12) 1.02 (0.53, 1.96)
Ever Mono 0.75 (0.38, 1.49) 0.74 (0.37, 1.46) 0.70 (0.28, 1.73) 0.97 (0.48, 1.97)
Current CD4+ T cell count 1.00 (0.9, 1.12) 1.01 (0.9, 1.13) 0.90 (0.77, 1.05) 1.01 (0.9, 1.14)
Current CD8+ T cell count 1.01 (0.94, 1.09) 1.01 (0.94, 1.09) 1.06 (0.96, 1.16) 0.99 (0.92, 1.07)
Log10 HIV RNA 0.74 (0.52, 1.05)
# 0.75 (0.53, 1.06) 0.86 (0.54, 1.36) 0.66 (0.45, 0.96)
*
*Statistically significant at p,0.05.
#Statistically significant at p,0.09.
doi:10.1371/journal.pone.0038419.t004
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classical responses.
The low prevalence of classical responses in HIV+ and HIV2
men is similar to the prevalence reported previously in HIV2 men
[33]. The unexpected trend toward association of lower frequency
of any nystagmus with HAART use suggests a possible therapeutic
relationship that requires further investigation. The reason for an
apparent relationship between increased HIV RNA and lower
likelihood of any nystagmus is unclear; it might be related to the
relatively small number of participants with detectable HIV RNA
[1,11]. The reason for the approximately equal frequency of
classical nystagmus among women and men in this study is
unknown [33]. As we expected to see twice as many women as
men with classical responses in HIV+ and HIV2 groups, the lack
of differences between men and women in the HIV+ group is
surprising.
The higher percentage of nonclassical nystagmus elicited by the
Dix-Hallpike maneuver may indicate BPPV of one of the anterior
semicircular canals, which is less common than BPPV of the
posterior semicircular canal [35,36], although the exact frequency
is unknown. Alternatively and more likely, because nonclassical
nystagmus is generally considered as a central sign [37], these
responses probably indicated impairments of the central vestibular
pathways in the brain [28]. Therefore, the relationship between
lower likelihood of nonclassical responses and current HAART use
suggests an effect of HAART on central neurologic function.
The frequency of Dix-Hallpike responses should be considered
in the context of the patterns of nystagmus. As expected, most
participants had negative responses. Since most BPPV patients
have unilaterally positive, classical responses and the prevalence of
BPPV has been estimated as 1.6% [33] we expected that only a few
subjects would have nonclassical responses. The surprisingly high
prevalence of nonclassical responses might be consistent with
impairments in oculomotor pathways.
The presence of gaze-evoked nystagmus among individuals who
were not having acute attacks of labyrinthitis or vestibular
neuronitis is consistent with involvement of central brain pathways
related to oculomotor control rather than disorders of the
peripheral vestibular system [38]. The finding of lower likelihood
of gaze-evoked nystagmus in HIV+ subjects who are currently
using HAART suggests a beneficial effect of HAART on central
neurologic function.
The presence of a positive head thrust response is consistent
with a clinically significant peripheral vestibular impairment. Men
had relatively few positive responses but men in this age group are
not known to have a high incidence of vestibular impairments.
The finding that women had no positive head thrust responses was
surprising because vestibular disorders are generally more
prevalent among women [39]. This finding offers some support
for the idea of a beneficial effect of HAART on the nervous
system.
The Romberg ECF is a secondary, yet important, measure.
Individuals with vestibular disorders are often impaired on
performance of this test and it is widely used clinically. The lack
of differences between HIV+ and HIV2 groups on this test
indicates that vestibularly mediated measures of balance were
unaffected by HIV status. The relationship between age and
failure on Romberg testing was expected. Age-related changes in
vestibular and balance function are well known
[40,41,42,43,44,45]. Most participants were middle-aged. If the
age ranges of the cohorts had been wider we might have found an
even stronger influence of age on balance scores. These age-
related balance changes did not appear to have functional
correlations, as yet.
This study had several strengths. Most study participants were
immunologically and virologically well-controlled [46,47], none of
whom had recently been diagnosed with any AIDS-defining
conditions at the time of testing, and the cohort had similar
numbers of male and female HIV+ individuals. Both cohorts are
well-characterized with all of the testing procedures performed
similarly. Participants were well known to the study staff and were
not intimidated by testing. They were advised to seek health care if
their test results showed positive responses and we established
mechanisms for participants to obtain specialized medical care if
they sought it. These humanitarian advantages to participants
resulted in high rates of participation and reliable data.
The study had some limitations. This study was cross-sectional
and therefore provides no data on the incidence of vestibular
impairments. A longitudinal study would be necessary to address
this question. Also, the VOG system did not allow calibration of
saccades to exactly the same location in space; consequently
measurement of gaze-evoked nystagmus was imprecise.
In general, our findings suggest that HIV infection treated with
HAART is not associated with the development of peripheral
vestibular impairments or premature aging of the vestibular
labyrinth [46]. The effectiveness of HAART to prevent the
progression of HIV is well established [47]. We have extended that
general finding to show that HAART use was positively associated
with a lower prevalence of vestibular impairment in community-
dwelling, HIV-infected individuals. The findings from gaze-evoked
nystagmus and nonclassical Dix-Hallpike responses might be
associated with increased centrally mediated oculomotor deficits,
perhaps consistent with mild neurologic disease found among
HIV-infected individuals [8,46].
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